Hematology/Oncology

Top Story

Nuclear receptors play key role in hormone-dependent malignancies

Nuclear receptors play key role in hormone-dependent malignancies
March 24, 2019
Meeting News

Experts debate CAR T-cell therapy vs. transplant for relapsed diffuse large B-cell lymphoma

March 23, 2019
NEW YORK — Chimeric antigen receptor T-cell therapy confers better outcomes than autologous stem cell transplant to some patients with relapsed diffuse large…

CAR T-cell therapy changing the landscape of lymphoma treatment

March 23, 2019
NEW YORK — Chimeric antigen receptor T cell therapies could be the breakthrough hematologists have sought to effectively treat certain patients with lymphoma…
Meeting News

Future ‘very bright’ in acute myeloid leukemia

March 23, 2019
NEW YORK — Treatment options for acute myeloid leukemia have evolved rapidly, but the expanded armamentarium has created a new set of challenges, according to a…
Meeting News

Speaker highlights burnout at Women in Endocrinology annual meeting

March 23, 2019
NEW ORLEANS — The advocacy group Women in Endocrinology is once again holding its annual meeting and dinner at ENDO 2019, spotlighting member achievements in the…
More Headlines »
CME ABIM MOC

Ace the Case: A 52-Year-Old Man with an Asymptomatic Neck Mass

There is no commercial support for this activity.

This educational activity will discuss the approach to diagnosis and management of a 52-year-old man who presents with…
More »
Video
Meeting News

VIDEO: Ibrutinib yields superior PFS vs. standard care in chronic lymphocytic leukemia

December 13, 2018
More »
Resource Centers
HemOnc Today New York

HemOnc Today New York

CME

Clinical Advances in Cutaneous T-cell Lymphoma: What You Need to Know About a Rare Malignancy

This activity is supported by an educational grant from Kyowa Kirin, Inc.

Cutaneous T-cell lymphoma (CTCL) is a rare and heterogeneous type of T-cell lymphoma that is often challenging to…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next